Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerhard Ehninger

Showing results (321-330 of 403) with videos related to

Pageof 41
Sort By:
Experimental Hematology|June 15, 2015
MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AMLTim Sauer, Maria Francisca Arteaga, Fabienne Isken, et al.
The Lancet. Haematology|March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trialFrederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.
Blood|June 20, 2020
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSimon Raffel, Daniel Klimmeck, Mattia Falcone, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 16, 2024
[ePROs in the routine care of a major oncology center: Results and experiences]Martin Eichler, Leopold Hentschel, Beate Hornemann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITDAnthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.
Blood|December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapyChristian Straka, Michael Sandherr, Hans Salwender, et al.
Blood|September 10, 2005
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domainFlorian Heidel, Fian K Solem, Frank Breitenbuecher, et al.
Bone Marrow Transplantation|February 27, 2022
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMTEdouard Forcade, Sylvie Chevret, Jürgen Finke, et al.
Haematologica|August 26, 2017
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8<sup>+</sup> cytotoxic T cellsFalk Heidenreich, Elke Rücker-Braun, Juliane S Walz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trialMarkus Schaich, Stefani Parmentier, Michael Kramer, et al.
Pageof 41

Showing results (321-330 of 403) with videos related to

Sort By:
Pageof 41
Experimental Hematology|June 15, 2015
MYST2 acetyltransferase expression and Histone H4 Lysine acetylation are suppressed in AMLTim Sauer, Maria Francisca Arteaga, Fabienne Isken, et al.
The Lancet. Haematology|March 19, 2018
Long-term efficacy of reduced-intensity versus myeloablative conditioning before allogeneic haemopoietic cell transplantation in patients with acute myeloid leukaemia in first complete remission: retrospective follow-up of an open-label, randomised phase 3 trialFrederick Fasslrinner, Johannes Schetelig, Andreas Burchert, et al.
Blood|June 20, 2020
Quantitative proteomics reveals specific metabolic features of acute myeloid leukemia stem cellsSimon Raffel, Daniel Klimmeck, Mattia Falcone, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|November 16, 2024
[ePROs in the routine care of a major oncology center: Results and experiences]Martin Eichler, Leopold Hentschel, Beate Hornemann, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2015
Allogeneic Stem Cell Transplantation Improves Survival in Patients with Acute Myeloid Leukemia Characterized by a High Allelic Ratio of Mutant FLT3-ITDAnthony D Ho, Johannes Schetelig, Tilmann Bochtler, et al.
Blood|December 18, 2010
Testing G-CSF responsiveness predicts the individual susceptibility to infection and consecutive treatment in recipients of high-dose chemotherapyChristian Straka, Michael Sandherr, Hans Salwender, et al.
Blood|September 10, 2005
Clinical resistance to the kinase inhibitor PKC412 in acute myeloid leukemia by mutation of Asn-676 in the FLT3 tyrosine kinase domainFlorian Heidel, Fian K Solem, Frank Breitenbuecher, et al.
Bone Marrow Transplantation|February 27, 2022
Impact of in vivo T-cell depletion in patients with myelodysplastic syndromes undergoing allogeneic hematopoietic stem cell transplant: a registry study from the Chronic Malignancies Working Party of the EBMTEdouard Forcade, Sylvie Chevret, Jürgen Finke, et al.
Haematologica|August 26, 2017
Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8<sup>+</sup> cytotoxic T cellsFalk Heidenreich, Elke Rücker-Braun, Juliane S Walz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trialMarkus Schaich, Stefani Parmentier, Michael Kramer, et al.
Pageof 41